Purinergic P2X4 receptor antagonist (Bayer)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePurinergic P2X4 receptor antagonist (Bayer)
Drug Alias NameP2X4 antagonist - Bayer
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 4 antagonists
TargetsP2X purinoceptor 4
Therapy Area/IndicationsEndometriosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsEndometriosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A